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Background:  Novel biomarkers representing pathophysiological pathways like inflammation, hemostasis and endothelial dysfunction are known 
to independently predict future cardiovascular events. We sought to assess their relationship with surrogate measures of visceral obesity in a healthy 
low risk multi-ethnic population.
Methods:  Multi-Ethnic study of Atherosclerosis (MESA) is a population based study (n=6,814) of White (38%), Black (28%), Chinese (22%) 
and Hispanic (12%) subjects, aged 45-84 yrs, free from clinical cardiovascular disease. We performed a post-hoc analysis of the NHLBI limited 
access dataset of MESA subjects (N=5534) to assess the relationship between a host of novel biomarkers with measures of anthropometry using 
multivariate adjusted linear regression analyses.
Results:  See Table 1
Conclusion: All measures of visceral obesity correlated significantly with novel biomarkers representing disparate biological pathways; although, 
the odds of having abnormal levels of biomarkers was higher with WHR and WHtR compared to other anthropometric measures. 
Table 1: Association between anthropometric measures and novel biomarkers 
Waist Circumference (WC) Waist-Hip Ratio (WHR) Waist-Height Ratio (WHtR)
Conicity Index
(CI)
Beta [95% CI] Beta [95% CI] Beta [95% CI] Beta [95% CI]
hsCRP (mg/L) 0.027 [0.025 to 0.029]*** 3.10 [2.71 to 3.49]*** 4.55 [4.22 to 4.89]*** 2.53 [2.23 to 2.82]***
Interleukin-6 (pg/mL) 0.016 [0.014 to 0.017]*** 1.83 [1.61 to 2.06]*** 2.58 [2.37 to 2.77]*** 1.51 [1.34 to 1.68]***
Plasmin-Antiplasmin Complex (nM) -0.004 [-0.005 to -0.003]*** -0.66 [-0.78 to -0.53]*** -0.65 [-0.77 to -0.54]*** -0.42 [-0.52 to -0.32]***
Fibrinogen (mg/dL) 0.0035 [0.003 to 0.004]*** 0.43 [0.36 to 0.50]*** 0.59 [0.53 to 0.66]*** 0.37 [0.31 to 0.42]***
D-dimer (mcg/mL) 0.008 [0.006 to 0.009]*** 0.80 [0.49 to 1.10]*** 1.24 [0.96 to 1.51]*** 0.68 [0.45 to 0.91]***
Factor-8 (%) 0.001 [0.0007 to 0.002]*** 0.21 [0.06 to 0.36]** 0.27 [0.14 to 0.40]*** 0.16 [0.05 to 0.27]**
Homocysteine (micromol/L) 0.001 [0.0005 to 0.001]*** 0.14 [0.04 to 0.24]** 0.17 [0.08 to 0.26]*** 0.10 [0.02 to 0.17]*
ICAM-1, (ng/ml) [N=2,315] 0.003 [0.002 to 0.0034]*** 0.54 [0.38 to 0.69]*** 0.49 [0.35 to 0.62]*** 0.31 [0.20 to 0.43]***
Odds Ratio [95% CI] Odds Ratio [95% CI] Odds Ratio [95% CI] Odds Ratio [95% CI]
Microalbuminuria[N=5,745] 1.02 [1.01 to 1.024]*** 5.32 [1.18 to 24.0]* 17.8 [4.65 to 67.8]*** 4.84 [1.50 to 15.6]**
Model is adjusted for age, sex, race, anti-hypertensive medications, smoking, lipid lowering therapy, recent Infection, total intentional exercise
*** p<0.001, **p<0.01 and *p<0.05.
Abbreviations: hsCRP: High sensitivity C- Reactive Protein; ICAM: intercellular adhesion molecule, CI: Confidence Interval
¶Microalbuminuria is defined as urine albumin/ creatinine ratio ≥30 to <300 mg/g of creatinine
